Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-02-26FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2010-02-26FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) from Merck Sharp & Dohme LLC, indicating modifications to its approved…
-
FDA approval · 2010-02-25FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for metformin hydrochloride filed by Oceanside Pharmaceuticals.
-
FDA approval · 2010-01-27FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for glipizide, authorizing changes to the approved generic product.
-
FDA approval · 2010-01-25FDA Approved: LIRAGLUTIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s original application for liraglutide (NDA 022341). The decision authorizes liraglutide for the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-01-22FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk. The approval pertains to the supplemental submissio…
-
FDA approval · 2010-01-19FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Glipizide and Metformin Hydrochloride from Teva Pharmaceuticals USA, Inc. The action approves ch…
-
FDA approval · 2009-12-30FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)
The FDA approved a supplemental application for Accord Healthcare's glimepiride product under an ANDA, granting regulatory clearance for the…
-
FDA approval · 2009-12-28FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck, resulting in an updated approval status for the drug.
-
FDA approval · 2009-12-28FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2009-11-30FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Glimepiride from Dr. Reddy's Laboratories Limited under an existing ANDA.
-
FDA approval · 2009-10-30FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2009-10-21FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) to update the product labeling.
-
FDA approval · 2009-10-02FDA Approved: WELCHOL — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original NDA for Welchol (colesevelam hydrochloride). Welchol is a bile acid sequestrant used to treat…
-
FDA approval · 2009-09-22FDA Approved: GLIMEPIRIDE — Original Application (Carlsbad Technology, Inc.)
The FDA approves the original abbreviated new drug application for GLIMEPIRIDE from Carlsbad Technology, Inc., enabling a generic version of…
-
FDA approval · 2009-09-14FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2009-09-09FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2009-09-09FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the pioglitazone and glimepiride fixed-dose combination submitted by Prasco Laboratories.
-
FDA approval · 2009-09-09FDA Approved: NATEGLINIDE — Original Application (Strides Pharma Science Limited)
FDA approved Nateglinide (Nateglinide) from Strides Pharma Science Limited under an original ANDA, enabling marketing of a generic meglitini…
-
FDA approval · 2009-09-09FDA Approved: NATEGLINIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original ANDA for nateglinide, a generic version of the meglitinide antidiabetic agent used …
-
FDA approval · 2009-08-31FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig.
-
FDA approval · 2009-07-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLOG (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk. The approval updates the labeling/indication fo…
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) submitted by Novo Nordisk.
-
FDA approval · 2009-07-09FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approved TEVA Pharmaceuticals USA Inc.'s supplemental application for glyburide. The drug is used to treat type 2 diabetes mellitus.